Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity

References

• Stull DE, Roberts L, Frank L, et al. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 2007;23:811-19
   PubMed Web of Science ®Google Scholar
• Storms W. Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Prim Care Respir J 2008;17:7-18
   PubMedGoogle Scholar
• Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28:3-9
   PubMed Web of Science ®Google Scholar
• Gurevich F, Glass C, Hughes K, et al. Handling congestion-related sleep disturbances in allergic rhinitis. J Respir Dis 2003;24:178-84
   Google Scholar
• Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 2004;130:617-29
   PubMed Web of Science ®Google Scholar
• Alexander M, Patel P, Allegro S, Hicks A. Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis. Clin Exp Ophthalmol 2003;31:206-12
   PubMed Web of Science ®Google Scholar
• Wallace DV, Dykewicz MS, Bernstein DI, et al.; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma, Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122(2 Suppl):S1-84
   PubMedGoogle Scholar
• Spangler DL, Abelson MB, Ober A, et al. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther 2003;25:2245-67
   PubMed Web of Science ®Google Scholar
• Alexander M, Berger W, Buchholz P, et al. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ). Health Qual Life Outcomes 2005;3:67
   PubMedGoogle Scholar
• Wood B. New treatments to relieve ocular allergies. Rev Optom 1999;136:124-35
   Google Scholar
• Knight A. The role of levocabastine in the treatment of allergic rhinoconjunctivitis. Br J Clin Pract 1994;48:139-43
   PubMedGoogle Scholar
• Pitt AD, Smith AF, Lindsell L, et al. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004;11:17-33
   PubMed Web of Science ®Google Scholar
• Ricard N, Kind P, Christian S, et al. Link between patient preferences and treatment outcomes in seasonal allergic rhinitis: an empiric investigation. Clin Ther 1999;21:268-77
   PubMed Web of Science ®Google Scholar
• Berger W, Abelson MB, Gomes PJ, et al. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol 2005;95:361-71
   PubMed Web of Science ®Google Scholar
• Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000;106:1019-32
   PubMed Web of Science ®Google Scholar
• Alexander M, Allegro S, Hicks A. Nedocromil sodium in golfers with seasonal allergic conjunctivitis. Adv Ther 2001;18:195-204
   PubMed Web of Science ®Google Scholar
• Pitt AD, Smith AF, Lindsell L, et al. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004;11:17-33
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004;34:952-7
   PubMed Web of Science ®Google Scholar
• Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003;111:484-90
   PubMed Web of Science ®Google Scholar
• Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 1996;11:278-88
   Web of Science ®Google Scholar
• Spritzer KL, Hays RD. MOS sleep scale: a manual for use and scoring. Santa Monica, CA: RAND Corporation, 2003
   Google Scholar
• Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the medical outcomes study sleep measure. Sleep Med 2005;6:41-4
   PubMed Web of Science ®Google Scholar
• Pratt EL, Craig TJ. Assessing outcomes from the sleep associated with rhinitis. Curr Opin Allergy Clin Immunol 2007;7:249-56
   PubMed Web of Science ®Google Scholar
• Watson D, Clark LA. The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form. [unpublished manuscript] Iowa City, IA: The University of Iowa; 1999 [updated 1999 August; cited 2007 March 13]; 27]. Available from: http://www.psychology.uiowa.edu/Faculty/Clark/PANAS-X.pdf
   Google Scholar